SWITZERLAND – GlaxoSmithKline’s ViiV Healthcare has committed to grant voluntary license on the patents for its injectable HIV prevention drug to make it more widely available in poorer nations, where…
Read MoreTag: MPP
US NIH warrants Covid-19 technologies to WHO and MPP
SWITZERLAND –The US National Institutes of Health (NIH) has agreed to license 11 Covid-19 technologies to the Medicines Patent Pool (MPP) via the World Health Organization’s Covid-19 Technology Access Pool…
Read More